Cart
sales@molnova.com
Mequitamium
CAS No. 101396-46-7
Mequitamium( —— )
Catalog No. M36192 CAS No. 101396-46-7
Mequitamium is an effective pharmaceutical intermediate that can be used to synthesize Mequitazium iodid.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 276 | In Stock |
|
| 10MG | 394 | In Stock |
|
| 25MG | 616 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMequitamium
-
NoteResearch use only, not for human use.
-
Brief DescriptionMequitamium is an effective pharmaceutical intermediate that can be used to synthesize Mequitazium iodid.
-
DescriptionMequitamium is an effective pharmaceutical intermediate that can be used to synthesize Mequitazium iodid.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number101396-46-7
-
Formula Weight337.5
-
Molecular FormulaC21H25N2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS1C=2C=CC=CC2N(C=3C=CC=CC13)CC4C[N+]5(C)CCC4CC5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
OVA G4 peptide TFA (...
G4 peptide (SIIGFEKL) is a variant of the agonist ovalbumin (OVA) peptide (257-264), SIINFEKL. OVA Peptide is a class I (Kb)-restricted peptide epitope of ovalbumin presented by the class I MHC (major histocompatibility complex) molecule, H-2Kb (class I genes of the mouse MHC).
-
ELOVL1-IN-3?
ELOVL1-IN-3 is a potent and orally active inhibitor of elongation of very long chain fatty acid 1 (ELOVL1) enzyme. ELOVL1-IN-3 serves as a useful tool for researching adrenoleukodystrophy (ALD).
-
Labetuzumab
Labetuzumab is a humanized anti-carcinoembryonic antigen (CEA) monoclonal antibody with anticancer activity that inhibits tumor growth and is used in the study of thyroid and colorectal cancer (CRC).
